Etodolac
Product Images NDC 42254-121

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 42254-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (9c244c88 Dcc4 44fb B0d9 13732dc705f5 01)

Image Of Chemical Structure (9c244c88 Dcc4 44fb B0d9 13732dc705f5 01)
Chemical structure diagram of the active ingredient Etodolac, showing its molecular framework including aromatic and cyclic components, an amine group, and a carboxylic acid functional group.*
FDA Label Image

Etodolac 300mg (9c244c88 Dcc4 44fb B0d9 13732dc705f5 02)

Etodolac 300mg (9c244c88 Dcc4 44fb B0d9 13732dc705f5 02)
Etodolac 300 mg capsules label by Rebel Distributors Corp, NDC 42254-121-90. The label indicates a bottle of 90 capsules, each containing 300 mg of Etodolac. The capsule is described as light pink gelatin with black imprint 'ETO 300mg' on cap and body. Manufacturer is Taro Pharmaceutical Industries Ltd., Israel. Storage instructions and packaging details are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.